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Annotation. In a clinical study, a new combination o f sodium hypochlorite and taurine for 
detoxifying activity was evaluated in patients with acute pancreatitis. Thus, the efficiency in the 
main group o f subjects who received the drug Neoreodes was 91.67%, which is significantly 
higher than the efficiency in the control group - 60.4%. Therefore, the hypothesis about the 
advantages o f treatment effectiveness in the main group ofsubjects in comparison with the control 
was confirmed. Calculations of pharmacoeconomic evaluation according to the methodology o f 
"cost-effectiveness" showed that the use o f "Neoreodesis" in thepharmacotherapeutic treatment 
regimen is inferior to the combination o f Sodium chloride 0.9% + glucose solution 5% in 
economic terms: CERneoreodesis 22.2 UAH/ e f and CERstand. ter. 14.5 UAH/ ef. However, it is 
important to note that in the group using Neoreodesis, a shorter stay o f patients in the intensive 
care unit was registered compared to the group receiving standard therapy.
Key words: fixed combination o f sodium and taurine hypochlorite, Neoreodesis, acute 
pancreatitis, "decision tree", cost-effectiveness o f treatment.
One of the problems of the modem clinics is chronic endotoxicosis, the manifestated 
by typical pathological process, are determined by organ and systemic reactions in 
the patient's body. The mechanisms of cytotoxic damage as a result of exposure to 
toxic products of lipid peroxidation (LPO) and due to the imbalance of the chains of 
immunological reactivity are closely related, which causes changes in the resulting 
cellular reactions that form the pathological process [1].
It is known that modem methods of extracorporeal detoxification, namely, 
hemodialysis and hemosorption, are insufficiently effective in removing hydrophobic 
toxins. It is known that the use of sodium hypochlorite is accompanied by a simultaneous 
decrease in both components of toxemia, and the severity of the effect increases as the 
syndrome of endogenous intoxication progresses. We first evaluated the detoxifying 
properties of a fixed combination of low-concentration sodium hypochlorite solution and 
taurine under conditions of endotoxicosis on the background of acute pancreatitis [2, 3].
It is known that acute pancreatitis is one of the most serious urgent diseases of 
the abdominal cavity. In terms of the share of treatment, it ranks third, second is acute 
appendicitis and cholecystitis. It accounts for up to 5-10% of urgent pathology of the 
abdominal cavity. At the same time, every fourth patient develops aseptic necrotic
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pancreatitis, the overall mortality of which even in specialized clinics around the world 
remains consistently high (level of evidence A, B), ranging from 2.1% to 15% [4]. In 
the infected form of pancreatic necrosis, mortality reaches 30-70%. In Ukraine, the 
incidence of acute pancreatitis is 102 per 100,000 population, the overall mortality 
ranges from 4 to 15% reaching 24-60% in the necrotic form, and postoperative mortality 
is 70%. Pathogenetic changes in acute pancreatitis are very diverse, covering many body 
systems. This explains the severity of the clinical course of the pathological process 
and in many cases - the emergence of severe multiorgan failure on the background of 
endotoxicosis [5, 6].
Therefore, the search for a new detoxifier today is an urgent problem for modem 
surgery.
The aim of the study was to determine the clinical and cost effectiveness of the new 
detoxifying agent "Neoreodesis" in patients with acute pancreatitis.
Research methods. Research design - open, randomized comparative, parallel.
The clinical study included 96 patients with acute pancreatitis. Patients based on 
the method of randomization in a ratio of 1: 1 were divided into the main group - 48 
patients and control - 48 patients. All patients received basic therapy (antispasmodics, 
proton pump inhibitors, protease inhibitors, somatostatin drugs, antibiotics). In addition, 
patients in the main group were prescribed an experimental infusion solution with the 
working name "Neoreodesis" for 3 days.
The effectiveness of treatment was evaluated by changes in the level of total 
bilirubin, blood amylase, urine diastase after 3 days of treatment compared with baseline. 
Treatment was considered successful if the level of at least two of the three evaluated 
indicators decreased by 35% from baseline or more. The safety of the drug was assessed 
on the basis of monitoring data on the patient's condition, frequency and nature of adverse 
reactions, laboratory data, assessment of the patient's subjective condition.
Pharmacoeconomic evaluation was performed using the "decision tree" model 
based on the cost-effectiveness indicator.
When performing the study, known clinical and statistical methods were used: 
quantitative analysis, variation statistics, comparison of efficiency between groups, 
determination of the efficiency unit [7].
Research results. Among the patients included in the clinical study there were 44 
female and 52 male patients. The distribution of patients by sex are presented in table. 
1. To assess the homogeneity on the basis of gender the chi-square Person criterion was 
used, taking into account the correction for continuity.
The diagnosis of acute pancreatitis was confirmed by assessment of blood amylase 
and urine diastase. Data from the initial assessment of the of blood amylase and urine 
diastase levels by methods of descriptive statistics arc presented in table 2.
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Table 1
Distribution of patients by sex
Gender
Main
Group
Control
group Total
n % n % n %
Male 27 56,25 25 52,08 52 54,17
Female 21 43,75 23 47,92 44 45,83
Total 48 100,0 48 100,0 96 100,0
Table 2
Analysis of the initial homogeneity of groups according to the 
assessment of blood amylase and urine diastase
Index Group N
Arithmetic
mean Median
Standard
deviation Min Max
blood
amylase,
mg/(g*ml)
Main 48 90,48 85,0 28,00 42 192
Control 48 94,48 86,0 25,29 70 189
urine
diastase,
g/g*l
Main 48 230,85 207,0 104,73 126 800
Control 48 237,08 219,0 67,86 119 410
Baseline levels o f blood amylase and urine diastase were significantly elevated. 
Based on the results o f statistical analysis, we can conclude that the groups did not differ 
significantly according to the initial data o f  the assessment o f blood amylase and urine 
diastase.
To assess the degree of endogenous intoxication the method of molecules of the 
medium weight (MMW) determining was used. The evaluation was performed by 
spectrometry in different modes X = 254 nm and X = 280 nm. In addition, the level o f 
malonic dialdehyde (MDA) was determined at the screening stage, which is a clinical 
and laboratory marker o f oxidative stress and blood pH. Data estimates o f the level o f 
molecules o f medium weight, and blood pH at the stage o f screening by methods o f 
descriptive statistics are given in table. 3.
Thus, in most subjects of the main group the level o f  total bilirubin, blood amylase 
and urine diastase by 35% or more was managed to reduce compared to the baseline.
During the clinical study, no adverse reactions that could be associated with the 
administration o f  the studied drug were reported. During the clinical study, a daily 
examination and interview of patients was performed to identify possible adverse 
reactions. Examination and interview o f patients o f the main group did not reveal 
any complaints, unexpected side effects, complications or intolerances o f the drug 
Neorcodesis when prescribed for 3 days. Patients did not complain and did not experience 
any unpleasant sensations that could be associated with the action o f the study drug. It 
did not have a negative effect on blood pressure, heart rate and body temperature: at the
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end of the clinical study there were no negative changes in these indicators compared to 
baseline before treatment in patients o f the main group.
Table 3
Analysis of the initial homogeneity of groups according to the assessment
of the medium molecular weight peptides level, MMW and PH blood
Index Group N
Arithmetic
mean Median
Standard
deviation Min Max
MMW in 
X = 254 
nm
Main 48 0,04 0,04 0,02 0,01 0,10
Control 48 0,05 0,05 0,04 0,01 0,24
MMW in 
X = 280 
nm
Main 48 0,08 0,07 0,13 0,01 0,98
Control 48 0,10 0,07 0,36 0,01 2,59
MDA
Main 48 3,02 2,87 0,94 1,24 5,92
Control 48 3,27 3,04 0,95 1,28 6,48
Blood PH
Main 48 7,38 7,38 0,04 7,31 7,47
Control 48 7,39 7,38 0,04 7,32 7,48
Laboratory parameters did not change negatively in any case, in most number of 
patients the level of leukocytes in the blood and the rate of erythrocyte sedimentation 
decreased, which indicates a decrease in the severity of the inflammatory reaction. 
Tolerability of treatment with the study drug in all cases was regarded as good.
Thus, the use of the drug "Neoreodes" as part o f basic therapy significantly increases 
the effectiveness of treatment in patients with acute pancreatitis compared with the 
administration of basic therapy alone.
Thus, the efficiency in the main group of patients who received the drug Neoreodes 
was 91.67%, which is significantly higher than the efficiency in the control group - 
60.4%. The hypothesis about the advantages of treatment effectiveness in the main group 
of subjects in comparison with the control was confirmed [8].
In assessing the economic component of the use of "Neoreodesis" in patients with 
endotoxicosis on the background of acute pancreatitis, a model of the "decision tree" 
was used.
Cost analysis was performed from the perspective of a patient who pays for a course 
of intoxication therapy. The modeling horizon is equal to the duration of the course of 
pharmacotherapy of peritonitis.
Calculations of pharmacoeconomic evaluation according to the methodology of 
"cost-effectiveness" showed that the use of "Neoreodesis" in the pharmacotherapcutic 
treatment regimen is inferior to the combination of Sodium chloride 0.9% + glucose 
solution 5% in economic terms: CERneoreodesis 22.2 UAH / ef and CERstand. ter. 14.5 
UAH / ef. However, it is important to note that in the group using Neoreodesis, a shorter 
stay of patients in the intensive care unit (ICU) was registered compared to the group 
receiving standard therapy (Fig. 1).
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Fig. 1. Model "decision tree" for pharmacoeconomic evaluation of the course of 
detoxification therapy of acute pancreatitis.
If the cost of the patient's stay in the ICU was taken into account when constructing 
the “decision tree” model, the financial burden was more significant for patients receiving 
standard therapy.
Conclusions. When analyzing the indexes of clinical efficacy and total costs in 
monetary terms for the course of detoxification therapy, namely, infusion solutions, the 
advantages of using a new combination of sodium hypochlorite in combination with 
taurine ("Neoreodesis") were determined.
Prospects for further research. In future, we plan further studies of the use of 
"Neoreodesis" in clinical practice under different conditions of endotoxicosis, such as 
peritonitis.
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